← Back to Search

RENEW for Scleroderma (RENEW Trial)

N/A

Waitlist Available

Led By Susan Murphy

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

RENEW Trial Summary

This trial is testing a program to see if it can help manage symptoms and the burden of scleroderma.

Eligible Conditions

Scleroderma

RENEW Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Fatigue

Secondary outcome measures

Change in Depressive symptoms

Change in Pain Interference

Change in Resilience

RENEW Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW)Experimental Treatment1 Intervention

RENEW was created by researchers, doctors, and patients with scleroderma. It is a web-based peer-led program to help manage energy and symptoms in people who have scleroderma.

Group II: WaitlistActive Control1 Intervention

Participants will be asked about changes in health status, and use of any new treatments or services at 6 and 12 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

RENEW

2021

N/A

~310

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,795 Previous Clinical Trials

6,373,762 Total Patients Enrolled

9 Trials studying Scleroderma

575 Patients Enrolled for Scleroderma

Rheumatology Research FoundationOTHER

9 Previous Clinical Trials

7,197 Total Patients Enrolled

1 Trials studying Scleroderma

5,000 Patients Enrolled for Scleroderma

Susan MurphyPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current vacancies in this trial available to participants?

"Affirmative. Clinicaltrials.gov supports the notion that this clinical trial is actively recruiting patients, with an initial post date of August 28th 2021 and a most recent update on September 21st 2022. The team needs 168 individuals from 1 medical centre to participate in the study."

Answered by AI

How many individuals are taking part in this clinical research?

"Affirmative. According to the information posted on clinicaltrials.gov, this medical study is actively seeking volunteers, with an initial posting date of August 28th 2021 and a recent update made on September 21st 2022. 168 participants are needed across one single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue

Susan Murphy 2021. "RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04908943.